Profil
Madiha Derouazi is the founder of Amal Therapeutics SA, founded in 2012, serving as Chief Executive Officer & Director since its founding.
The current job is Chief Executive Officer at Switchkine SA starting in 2025.
Former jobs include Chief Executive Officer at Speransa Therapeutics GmbH and Chief Scientific Officer at AC Immune SA. Education includes graduate studies at the Technical University of Berlin and a doctorate from the Swiss Federal Institute of Technology.
Aktive Positionen von Madiha Derouazi
| Unternehmen | Position | Beginn |
|---|---|---|
Amal Therapeutics SA
Amal Therapeutics SA BiotechnologyHealth Technology Operates a proprietary cell penetrating peptide platform which develops therapeutic vaccines in oncology | Gründer | 03.09.2012 |
Ehemalige bekannte Positionen von Madiha Derouazi
| Unternehmen | Position | Ende |
|---|---|---|
| AC IMMUNE SA | Technik-/Wissenschafts-/F&E-Leiter | - |
Ausbildung von Madiha Derouazi
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 4 |
|---|---|
AC Immune SA
AC Immune SA Pharmaceuticals: MajorHealth Technology Manufactures precision medicines for neurodegenerative diseases | Health Technology |
Technical University of Berlin
Technical University of Berlin Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Swiss Federal Institute of Technology
Swiss Federal Institute of Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Amal Therapeutics SA
Amal Therapeutics SA BiotechnologyHealth Technology Operates a proprietary cell penetrating peptide platform which develops therapeutic vaccines in oncology | Health Technology |
















